Features

Management of Oligometastatic PCa

More and more cases of oligometastatic PCa are being diagnosed as a result of advances in molecular imaging, but clinical trial data about the best ...

Avoid Biopsy for Elevated PSA?

Multiparametric magnetic resonance imaging in conjunction with transrectal ultrasound-guided biopsy improves discrimination between clinically significant and insignificant prostate tumors and can spare patients unnecessary biopsies.

3D Printed Prostates Could Improve RP

New technique uses silicone-based polymer inks to create prostate models with the tactile sensation, pliability, and texture of a real prostate.

Outpatient Transperineal Prostate Biopsy

The transperineal approach to prostate biopsy has recently been adopted at many centers as an alternative to TRUS-B.

PET/CT for Prostate Cancer

Novel PET radiotracers have shown great potential in the early diagnosis and staging of PCa, detection of post-treatment recurrence, and monitoring of metastases not previously ...

RP vs Radiation for High-Risk PCa

Physicians who treat patients with high-risk prostate cancer remain uncertain as to the optimal treatment approach, in part due to difficulty in interpreting study data.

New PCa Grading System Embraced

Endorsed by the International Society of Urological Pathology in 2014, the 5-tier Gleason grade group system is used routinely today in pathology reports and physician ...

Overuse of PCa Scans May Be Easing

Efforts by physician groups in recent years to discourage inappropriate use of radiologic imaging for the initial staging of men with newly diagnosed low-risk disease ...

The Role of MRI in Prostate Cancer Management

An interview with Ashutosh K. Tewari, MBBS, MCh

Latest Prostate Cancer News

Prostate Cancer Vaccine Found Not to Improve Survival

Prostate Cancer Vaccine Found Not to Improve Survival

In a phase 3 trial, Prostvac-V/F did not significantly prolong overall survival among men with asymptomatic or minimally symptomatic mCRPC.

End-of-Life Prostate Cancer-Related Complications Characterized

End-of-Life Prostate Cancer-Related Complications Characterized

Men with advanced prostate cancer at diagnosis have an elevated risk of spinal cord compression, renal failure, and other cancer-related morbidities.

Prostate Biopsy Complications Deter Patients From Re-Biopsy

Prostate Biopsy Complications Deter Patients From Re-Biopsy

Study participants with acute urinary retention after TRUS-guided prostate biopsy were 4.5 times more likely to skip a recommended re-biopsy than men who had no initial biopsy-related complications.

Long-Term Data Support Finasteride for PCa Prevention

Long-Term Data Support Finasteride for PCa Prevention

Clinicians can rest easier about recommending finasteride to more men, according to experts.

Prostate Cancer Treatment Side Effects Linked to Distress

Prostate Cancer Treatment Side Effects Linked to Distress

Those with worse emotional distress also report worse urinary, sexual, bowel functions.

Biparametric MRI Improves Detection of Significant PCa

Biparametric MRI Improves Detection of Significant PCa

If externally validated, bpMRI could be used to triage men for prostate biopsy.

Abiraterone for mCRPC May Benefit Blacks More Than Whites

Abiraterone for mCRPC May Benefit Blacks More Than Whites

Abiraterone plus prednisone was associated with significantly greater PSA progression-free survival among patients who are black compared with white patients.

Robotics Involved in Most Urologic Cancer Surgeries

Robotics Involved in Most Urologic Cancer Surgeries

In 2015, 69% of surgeries for prostate, bladder, and kidney cancer were performed with robotic assistance, a new meta-analysis shows.

Enzalutamide for Advanced Prostate Cancer Does Not Worsen HRQoL

Enzalutamide for Advanced Prostate Cancer Does Not Worsen HRQoL

Enzalutamide decreases the risk of clinically meaningful deterioration in HRQoL compared with placebo in men with non-metastatic CRPC, new study finds.

AUA Updates Castration-Resistant Prostate Cancer Clinical Guideline

AUA Updates Castration-Resistant Prostate Cancer Clinical Guideline

"We are confident this guideline is fully aligned with the latest science on treatments for patients with non-metastatic and metastatic CRPC," said Michael Cookson, MD, member of the 2018 amendment panel.

PSA Level 3 Months After Radiation Tx May Predict Outcome

PSA Level 3 Months After Radiation Tx May Predict Outcome

Findings for men with intermediate- and high-risk prostate cancer.

Current Smokers at Risk for Worse Prostate Cancer Outcomes

Current Smokers at Risk for Worse Prostate Cancer Outcomes

In a meta-analysis, smokers had an 89% greater risk of dying from prostate cancer compared with nonsmokers.

FDA Approves Yonsa for Metastatic Castration-Resistant Prostate Cancer

FDA Approves Yonsa for Metastatic Castration-Resistant Prostate Cancer

The approval of Yonsa was based on 2 randomized, placebo-controlled, multicenter Phase 3 studies in patients with mCRPC.

From 2008 to 2014, Prostate Cancer Testing, Treatment Down

From 2008 to 2014, Prostate Cancer Testing, Treatment Down

Sharpest decrease seen in privately insured men after 2011.

Laser Focal Ablation of Prostate Cancer Improves Outcomes

Laser Focal Ablation of Prostate Cancer Improves Outcomes

Men with low-risk PCa who underwent partial gland ablation with vascular-targeted photodynamic therapy were less likely than those on AS to require radical treatment.

Sign up for free e-Newsletters